Literature DB >> 21571184

A melanoma subtype: uveal melanoma.

Julia Wu, Georg Brunner, Julide Tok Celebi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21571184      PMCID： PMC3096830          DOI： 10.1016/j.jaad.2010.06.004

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  9 in total

1.  Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations.

Authors:  Jürgen Bauer; John A Curtin; Dan Pinkel; Boris C Bastian
Journal:  J Invest Dermatol       Date:  2006-08-03       Impact factor: 8.551

2.  Somatic activation of KIT in distinct subtypes of melanoma.

Authors:  John A Curtin; Klaus Busam; Daniel Pinkel; Boris C Bastian
Journal:  J Clin Oncol       Date:  2006-08-14       Impact factor: 44.544

3.  High BRAF mutation frequency does not characterize all melanocytic tumor types.

Authors:  Gerald Saldanha; David Purnell; Alan Fletcher; Linda Potter; Angela Gillies; J Howard Pringle
Journal:  Int J Cancer       Date:  2004-09-20       Impact factor: 7.396

Review 4.  Emerging insights into the molecular pathogenesis of uveal melanoma.

Authors:  Solange Landreville; Olga A Agapova; J William Harbour
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

5.  Oncogenic mutations in GNAQ occur early in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Meghan D Long; Shenghui Duan; M Laurin Council; Anne M Bowcock; J William Harbour
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-21       Impact factor: 4.799

Review 6.  Melanoma biology and new targeted therapy.

Authors:  Vanessa Gray-Schopfer; Claudia Wellbrock; Richard Marais
Journal:  Nature       Date:  2007-02-22       Impact factor: 49.962

7.  Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.

Authors:  Catherine D Van Raamsdonk; Vladimir Bezrookove; Gary Green; Jürgen Bauer; Lona Gaugler; Joan M O'Brien; Elizabeth M Simpson; Gregory S Barsh; Boris C Bastian
Journal:  Nature       Date:  2008-12-10       Impact factor: 49.962

8.  Mutational profile of GNAQQ209 in human tumors.

Authors:  Simona Lamba; Lara Felicioni; Fiamma Buttitta; Fonnet E Bleeker; Sara Malatesta; Vincenzo Corbo; Aldo Scarpa; Monica Rodolfo; Margaret Knowles; Milo Frattini; Antonio Marchetti; Alberto Bardelli
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

9.  Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system.

Authors:  Heidi V N Küsters-Vandevelde; Annelies Klaasen; Benno Küsters; Patricia J T A Groenen; Ilse A C H van Engen-van Grunsven; Marcory R C F van Dijk; Guido Reifenberger; Pieter Wesseling; Willeke A M Blokx
Journal:  Acta Neuropathol       Date:  2010-03       Impact factor: 17.088
  9 in total
  2 in total

1.  Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.

Authors:  Aaron B Beasley; Timothy W Isaacs; Tersia Vermeulen; James Freeman; Jean-Louis DeSousa; Riyaz Bhikoo; Doireann Hennessy; Anna Reid; Fred K Chen; Jacqueline Bentel; Daniel McKay; R Max Conway; Michelle R Pereira; Bob Mirzai; Leslie Calapre; Wendy N Erber; Melanie R Ziman; Elin S Gray
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

Review 2.  Update on uveal melanoma: Translational research from biology to clinical practice (Review).

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Natalio García-Honduvilla; Santiago Coca; Melchor Álvarez-Mon; Julia Buján; Miguel A Teus
Journal:  Int J Oncol       Date:  2020-10-22       Impact factor: 5.650
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.